SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Gilead Science (GILD) Followers
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
961 87 0 GILD
Emcee:  SybilNicolas Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
586 U.S. FDA panel rejects new flu drug GAITHERSBURG, Md., Feb 24 (Reuters) - A Uscaram(o)uche-2/24/1999
585 CNBC says vote was 13 to 4 against. That isn't even close. Should be intescaram(o)uche-2/24/1999
584 what part of "Glaxo dinged" didn't you understand? :-) The quesscaram(o)uche-2/24/1999
583 I assume it was because of Glaxo's flu drug Relenza being turned down by anBiomaven-2/24/1999
582 Look at the late trading today---sudden surge on high volume while the rest of Maven1-2/24/1999
581 Glaxo dinged. Should be interesting to see commentary from the committee.scaram(o)uche-2/24/1999
580 The January Scientific American has a nice article on Neuraminidase inhibitors.tnsaf-2/2/1999
579 A nice inverse relationship...the board slumbers as the stock climbs! I can liLarry Liebman-12/29/1998
578 The Lancet Publishes The First Ever Phase III Clinical Trial Involving a Neurams jones-12/14/1998
577 If you don't have AA, the info is linked to the anti-HIV table on the New THenry Niman-11/14/1998
576 Lehman on HIV market 1999- 2002 you'll need Adobe Acrobat lehman.comTrey Yon-11/14/1998
575 This morning BBRS came out with a BUY rec and Paine Webber came out with an ATTHenry Niman-11/9/1998
574 Bloomberg report on Preveon was strongly worded. See anti-HIV table on New TherHenry Niman-11/8/1998
573 Seems to be a lot of good news lately for patients and investors (particularly Paul Kelly-11/8/1998
572 Here's more. Pretty heavy-duty release...... biz.yahoo.comscaram(o)uche-11/8/1998
571 All I can say is that if 20% of the patients who took the drug seroconverted, tDoug Meetmer-11/6/1998
570 It's the active ingredient in Preveon(AIDS). Similar results published in APaul Kelly-11/6/1998
569 News: biz.yahoo.com Was this already known/published? Affect on GILD?? DaveDave Walp-11/6/1998
568 Off the fence & long again @21; just couldn't stay away any longer, nicTrey Yon-10/12/1998
567 New Pill Reduces Bout With Flu SEPTEMBER 25, 01:21 EDT By DANIEL Q. HANEY AAnthony Wong-9/25/1998
566 Sept. 24 - Gilead Sciences Inc. Reiterated 'Strong Buy' at Prudential Anthony Wong-9/25/1998
565 Gilead's Pill Shown Effective to Prevent, Treat Flu (Update2) BloombAnthony Wong-9/25/1998
564 Betting on biotechs By CBS MarketWatch Last Anthony Wong-9/24/1998
563 Mike...thanks . saadi taher-9/23/1998
562 Late-breaker abstract at ICAAC article at thestreet.com thestreet.comMike McFarland-9/23/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News